Abstract
The nephrotic syndrome was induced in rats by intravenous adriamycin (3 mg/kg). The rats were then divided into four groups which, for six weeks, were pair-fed diets containing beef tallow (BT), fish oil (FO), a source of n−3 fatty acids, evening primrose oil (EPO), a source of n−6 fatty acids, or a combination of evening primrose oil and fish oil, 75∶25 (EPO:FO). The fat content of the diets was 15%. Significant incorporation of the fatty acids into kidney phospholipids was demonstrated. Diets containing FO, EPO and EPO:FO lowered plasma triglycerides and total cholesterol levels as compared with diets containing BT. Only EPO:FO raised high density lipoprotein (HDL) cholesterol levels, as compared with BT. The combination EPO:FO prevented the tenfold suppression of aortic 6-keto-PGF1α caused by FO. These changes in plasma lipids and eicosanoid production are potentially antiatherogenic and may prevent glomerular sclerosis. The combination of EPO and FO, containing n−6 and n−3 fatty acids may offer advantages over either family of fatty acids in this model of nephrotic syndrome.
Similar content being viewed by others
Abbreviations
- BSA:
-
bovine serum albumin
- BT:
-
beef tallow
- EBSS:
-
Earls Balanced Salt Solution
- EPO:
-
evening primrose oil
- FO:
-
fish oil
- HDL:
-
high density lipoprotein
- PG:
-
prostaglandin
- PUFA:
-
polyunsaturated fatty acid
- SBO:
-
soybean oil
- TXA2 :
-
thromboxane A2
- (V)LDL:
-
(very) low density lipoprotein
- GC:
-
gas chromatography
- HPLC:
-
high-performance liquid chromatography
- PAS:
-
periodic acid-Schiff
- RIA:
-
radioimmunoassay
References
Ito, Y., Barcelli, U., Yamashita, W., Weiss, M., Thompson, B., Kashyap, M., Deddens, J., and Pollak, V.E. (1987)Life Sci. 40, 2317–2324.
Ito, Y., Barcelli, U., Yamashita, W., Weiss, M., Kashyap, M., Glas-Greenwalt, P., and Pollak, V.E. (1988)Metabolism 37, 352–357.
Folch, J., Lees, M., and Sloane-Stanley, G.H. (1957)J. Biochem. Chem. 226, 497–509.
Juaneda, P., and Rocquelin, G. (1985)Lipids 20, 40–41.
Hassid, A., Konieczkowski, M., and Dunn, M.J. (1979)Proc. Natl. Acad. Sci. USA 76, 1155–1159.
Gallon, L.S., and Barcelli, U.O. (1986)Prostaglandins 31, 217–225.
Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. (1951)J. Biol. Chem. 193, 265–277.
Phillipson, B.E., Rothrock, D.W., Connor, W.E., Harris, W.S., and Illingworth, D.R. (1985)N. Engl. J. Med. 312, 1210–1216.
Tsukamoto, Y., Okubo, M., Tomiko, Y., Marumo, F., and Nakamura, H. (1982)Nephron 31, 236–241.
Harris, W.S., Connor, W.E., and McMurry, M.P. (1983)Metabolism 32, 179–184.
Wong, S.H., Nestel, P.J., Trimble, R.P., Storer, G.B., Illman, R.J., and Topping, D.L. (1984)Biochim. Biophys. Acta 792, 103–109.
Nestel, P.J., Connor, W.E., Reardon, M.F., Connor, S., Wong, S., and Boston, R. (1984)J. Clin. Invest. 74, 82–89.
Illingworth, D.R., Harris, W.S., and Connor, W.E. (1984)Arteriosclerosis 4, 270–275.
Davis, H.R., Bridenstine, R.T., Vesselinovitch, D., and Wissler, R.W. (1987)Arteriosclerosis 7, 441–449.
Sanders, T.A.B., Sullivan, D.R., Reeve, J., and Thompson, G.R. (1985)Arteriosclerosis 5, 459–465.
Rylance, P.B., Gordge, M.P., Saynor, R., Parsons, V., and Weston, M.J. (1986)Nephron 43, 196–202.
Saynor, R., Verel, D., and Gillott, T. (1984)Atherosclerosis 50, 3–10.
van Acker, B.A.C., Bilo, H.J.G., Popp-Snijders, C., van Bronswijk, H., Oe, P.L., and Donker, A.J.M. (1987)Nephrol. Dial. Transplant. 2, 557–561.
Sanders, T.A.B., and Hochland, M.C. (1983)Br. J. Nutr. 50, 521–529.
Huang, Y.S., Nassar, B.A., and Horrobin, D.F. (1986)Biochim. Biophys. Acta 879, 22–27.
Cook, H.W., and Spence, M.W. (1987)Lipids 22, 613–619.
Barcelli, U.O., Weiss, M., and Pollak, V.E. (1982)J. Lab. Clin. Med. 100, 786–797.
Barcelli, U., Miyata, J., Ito, Y., Gallon, L., Laskarzewski, P., Weiss, M., Hitzemann, R., and Pollak, V. (1982)Prostaglandins 32, 211–219.
Diamond, J.R., and Karnovsky, M.J. (1988)Kidney Int. 33, 917–924.
Diamond, J.R., and Karnovsky, M.J. (1987)Kidney Int. 32, 671–677.
Author information
Authors and Affiliations
About this article
Cite this article
Barcelli, U.O., Beach, D.C., Thompson, B. et al. A diet containing n−3 and n−6 fatty acids favorably alters the renal phospholipids, eicosanoid synthesis and plasma lipids in nephrotic rats. Lipids 23, 1059–1063 (1988). https://doi.org/10.1007/BF02535652
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02535652